NYSE:ABTMedical Equipment
Abbott Laboratories (ABT) Margin Drop To 13.9% Challenges Bullish Earnings Narratives
Abbott Laboratories (ABT) opened 2026 with Q1 revenue of US$11.2b and basic EPS of US$0.62, setting the tone for how the rest of the year could shape up against prior momentum. Over recent quarters the company has seen revenue move from US$10.4b in Q1 2025 to between roughly US$11.1b and US$11.5b across the rest of 2025, while quarterly EPS has ranged from US$0.76 to just over US$1.00. This gives a clear sense of how the top and bottom lines have tracked into the latest print. With a trailing...